about
An Elective Course on Antimicrobial Stewardship.Heat-stable ritonavir tablets: a new formulation of a pharmacokinetic enhancer for HIV.Cobicistat: Review of a Pharmacokinetic Enhancer for HIV Infection.ASHP Guidelines on Pharmacist Involvement in HIV Care.Elvitegravir for the treatment of HIV.Pharmacist engagement within a hepatitis C ambulatory care clinic in the era of a treatment revolution.Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.Baseline-transmitted V106V/I/M non-nucleoside reverse transcriptase inhibitor resistance in HIV-1 subtype B infection.Pharmacist testers in multidisciplinary health care team expand HIV point-of-care testing program.Strength in Amalgamation: Newer Combination Agents for HIV and Implications for Practice.Role of Residency Interview Preparatory Activities as a Determinant on Pharmacy Residency Match Rates.Patient Perceptions of Text Messaging to Improve Antiretroviral Therapy Adherence: A Qualitative Study of Patients in a Ryan White Clinic.Clinical infectious diseases pharmacists in the United States: a problem of both supply and demandIntegrase Inhibitors: After 10 Years of Experience, Is the Best Yet to Come?Effect of Health Insurance on Hepatitis C Sustained Virologic Response Rates to Sofosbuvir-Based Treatment Regimens in a South Florida Community HospitalEffect of mobile text messages on antiretroviral medication adherence and patient retention in early HIV care: an open-label, randomized, single center study in south Florida
P50
Q36569294-ECE3375D-493B-4FD4-807A-B5954DEF0840Q37818237-1C472460-B3DE-4D33-961F-4FE94A667AB5Q38576211-44BF7BF4-6A74-4F2A-8AB6-AA3EDB1F059CQ38739944-23FD5F55-DE51-4A94-A72D-CFD6B094D507Q38987327-5AFCF782-21D9-4102-8E4C-B88282BCD7EAQ39352535-E2EA6979-7AEA-4CF9-B258-8EEACB3947DEQ41689446-C7928608-FD48-4CE4-9379-D3B5A9B84835Q41812289-26BFF3E7-6ECB-439B-B0DA-FFB2D8A50EA1Q44289454-A911CDF5-A51D-4E47-BB21-85AFFB42ED47Q45961010-41C32D2D-EE9E-46B4-97CA-5231E319D108Q48063344-DB2F27AC-BA00-4684-8D25-4C7DAC9AF4B9Q54267929-B2B19C4A-FE9A-49B4-8038-E477929448A4Q86022264-E653BD6C-0393-4837-ACFC-CD1E16179576Q92297338-FC815346-475F-467E-9004-15E024FB814AQ92680552-C999FA3F-92C6-492E-B834-8A23656EC3C9Q94668425-75DD31C8-5BDD-4326-A291-70D8CBA2415E
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Elizabeth M Sherman
@en
Elizabeth M Sherman
@nl
type
label
Elizabeth M Sherman
@en
Elizabeth M Sherman
@nl
prefLabel
Elizabeth M Sherman
@en
Elizabeth M Sherman
@nl
P31
P496
0000-0002-6559-0684